Salazar Miguel Ángel, Chavez-Galan Leslie, Castorena-Maldonado Armando, Mateo-Alonso Maribel, Diaz-Vazquez Nadia Otilia, Vega-Martínez Ana María, Martínez-Orozco José Arturo, Becerril-Vargas Eduardo, Sosa-Gómez Fernando Manuel, Patiño-Gallegos Hilda, Alonso-Martínez Delfino, López-Segundo Enrique, Vidal Fernando, Velasco-González Luis Joan, Pérez-Pulido Silvia, Santillán-Doherty Patricio, Regalado-Pineda Justino, Salas-Hernández Jorge, Buendía-Roldán Ivette
Instituto Nacional de Enfermedades Respiratorias Ismael Cosio Villegas, Mexico, Mexico.
Front Public Health. 2021 Apr 13;9:651144. doi: 10.3389/fpubh.2021.651144. eCollection 2021.
Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Healthcare workers (HCWs) constitute a population which is significantly affected by SARS-CoV-2 infection worldwide. In Mexico, the (INER) is the principal national reference of respiratory diseases. To evaluate the efficiency of the INER-POL-TRAB-COVID19 program to mitigate the SARS-CoV-2 infection risk among the INER-healthcare workers (INER-HCW). Currently, the INER has 250 beds and 200 respiratory ventilators to support COVID-19 patients in critical condition. On March 1st, 2020, the INER-POL-TRAB-COVID19 program was launched to mitigate the SARS-CoV-2 infection risk among the INER-HCW. From March 1st to October 1st, 2020, 71.5% of INER-HCWs were tested for SARS-CoV-2 infection, and 77% of them were frontline workers. Among the tested INER-HCWs, 10.4% were positive for SARS-CoV-2 infection. Nonetheless, nosocomial infection represented only 3.8% of the cases and the mortality was null. Fifty-three of INER-HCWs positive to SARS-CoV-2 had a negative test 42-56 days post-diagnosis and were returned to service. Finally, although a change in the PPE implemented on May 11th, 2020, the incidence of SARS-CoV-2 infection was not affected. INER has a lower incidence of HCWs infected with SARS-CoV-2 as compared to the mean of the national report. The implementation of the INER-POL-TRAB-COVID19 program is efficient to decrease the risk of infection among the HCWs. Our findings suggest that the implementation of a similar program at a national level can be helpful to provide a safe environment to HCWs and to prevent the collapse of health institutions.
2019冠状病毒病(COVID-19)由严重急性呼吸综合征冠状病毒2(SARS-CoV-2)引起。医护人员是全球范围内受SARS-CoV-2感染影响显著的人群。在墨西哥,国家呼吸系统疾病研究所(INER)是全国呼吸疾病的主要参考机构。为评估INER-POL-TRAB-COVID19项目在降低INER医护人员(INER-HCW)感染SARS-CoV-2风险方面的成效。目前,INER有250张床位和200台呼吸呼吸机,用于支持重症COVID-19患者。2020年3月1日,启动了INER-POL-TRAB-COVID19项目,以降低INER-HCW感染SARS-CoV-2的风险。在2020年3月1日至10月1日期间,71.5%的INER-HCW接受了SARS-CoV-2感染检测,其中77%为一线工作人员。在接受检测的INER-HCW中,10.4%的SARS-CoV-2感染呈阳性。尽管如此,医院感染病例仅占3.8%,且无死亡病例。53名SARS-CoV-2检测呈阳性的INER-HCW在诊断后42 - 56天检测结果转为阴性,并重返工作岗位。最后,尽管2020年5月11日实施了个人防护装备的更换,但SARS-CoV-2感染的发生率并未受到影响。与全国报告的平均水平相比,INER的医护人员感染SARS-CoV-2的发生率较低。INER-POL-TRAB-COVID19项目的实施在降低医护人员感染风险方面是有效的。我们的研究结果表明,在国家层面实施类似项目有助于为医护人员提供安全的环境,并防止卫生机构崩溃。